Industries · Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Top biotechnology: biological products (no diagnostic substances) companies by market capitalization, ranked. Click through for real-time filings and ratings on any ticker. 248 companies tracked.
- 1AMGNAmgen Inc.$182.21B
- 2GILDGilead Sciences Inc.$153.66B
- 3ARGXargenx SE$54.47B
- 4RVMDRevolution Medicines Inc.$34.65B
- 5BIIBBiogen Inc.$29.02B
- 6MRNAModerna Inc.$25.38B
- 7SGENSeagen Inc.$23.34B
- 8BNTXBioNTech SE$22.84B
- 9NBIXNeurocrine Biosciences Inc.$15.92B
- 10EXELExelixis Inc.$13.05B
- 11XLRNAcceleron Pharma Inc.$10.93B
- 12KRYSKrystal Biotech Inc.$10.26B
- 13TECHBio-Techne Corp$9.07B
- 14HALOHalozyme Therapeutics Inc.$8.13B
- 15IBRXImmunityBio Inc.$7.71B
- 16QGENQiagen N.V.$7.61B
- 17RGENRepligen Corporation$7.45B
- 18KYMRKymera Therapeutics Inc.$7.44B
- 19IMVTImmunovant Inc.$7.26B
- 20APGEApogee Therapeutics Inc.$6.81B
- 21ACLXArcellx Inc.$6.73B
- 22SRRKScholar Rock Holding Corporation$5.67B
- 23TWSTTwist Bioscience Corporation$5.45B
- 24CGONCG Oncology Inc.$5.39B
- 25CRSPCRISPR Therapeutics AG$5.22B
- 26ABCMAbcam plc$4.59B
- 27DNLIDenali Therapeutics Inc.$3.70B
- 28BEAMBeam Therapeutics Inc.$3.51B
- 29RLAYRelay Therapeutics Inc.$3.04B
- 30ADPTAdaptive Biotechnologies Corporation$2.81B
- 31TARSTarsus Pharmaceuticals Inc.$2.72B
- 32SWTXSpringWorks Therapeutics Inc.$2.59B
- 33BCRXBioCryst Pharmaceuticals Inc.$2.28B
- 34KODKodiak Sciences Inc$2.26B
- 35VCELVericel Corporation$2.05B
- 36ADMAADMA Biologics Inc$1.93B
- 37MESOMesoblast Limited$1.85B
- 38TSHATaysha Gene Therapies Inc.$1.84B
- 39IOVAIovance Biotherapeutics Inc.$1.75B
- 40RXRXRecursion Pharmaceuticals Inc.$1.71B
- 41GLUEMonte Rosa Therapeutics Inc.$1.55B
- 42VIRVir Biotechnology Inc.$1.54B
- 43NVAXNovavax Inc.$1.50B
- 44NSTGNanoString Technologies Inc.$1.48B
- 45MAZEMaze Therapeutics Inc.$1.42B
- 46IMCRImmunocore Holdings plc$1.38B
- 47INBXInhibrx Biosciences Inc.$1.37B
- 48IMTXImmatics N.V.$1.31B
- 49ITOSiTeos Therapeutics Inc.$1.23B
- 50ALVOAlvotech$1.22B
- 51MGTXMeiraGTx Holdings plc$1.05B
- 52CGEMCullinan Therapeutics Inc.$923.7M
- 53DBVTDBV Technologies S.A.$919.5M
- 54SANASana Biotechnology Inc.$876.6M
- 55REPLReplimune Group Inc.$841.4M
- 56SLDBSolid Biosciences Inc.$820.1M
- 57VORVor Biopharma Inc.$785.2M
- 58ALLOAllogene Therapeutics Inc.$690.3M
- 59AURAAura Biosciences Inc.$655.5M
- 60CADLCandel Therapeutics Inc.$608.9M
- 61ADAPAdaptimmune Therapeutics plc$593.1M
- 62PRMEPrime Medicine Inc.$583.4M
- 63VXRTVaxart Inc$576.0M
- 64RUBYRubius Therapeutics Inc.$574.2M
- 65DNAGinkgo Bioworks Holdings Inc.$569.8M
- 66TECXTectonic Therapeutic Inc.$566.5M
- 67PROKProKidney Corp.$552.8M
- 68AGMBAgomAb Therapeutics NV$540.7M
- 69BLUEbluebird bio Inc.$527.9M
- 70EIKNEikon Therapeutics Inc.$520.3M
- 71VALNValneva SE$510.5M
- 72FDMT4D Molecular Therapeutics Inc.$505.0M
- 73OMGAOmega Therapeutics Inc.$494.5M
- 74STROSutro Biopharma Inc.$491.0M
- 75KYTXKyverna Therapeutics Inc.$490.6M
- 76ALVRAlloVir Inc.$479.4M
- 77CABACabaletta Bio Inc.$463.1M
- 78CCCCC4 Therapeutics Inc.$458.9M
- 79OCGNOcugen Inc.$419.8M
- 80VIGLVigil Neuroscience Inc.$414.1M
- 81IPSCCentury Therapeutics Inc.$413.0M
- 82RGNXREGENXBIO Inc.$403.2M
- 83AUTLAutolus Therapeutics plc$401.9M
- 84XFORX4 Pharmaceuticals Inc.$398.0M
- 85SOPHSOPHiA GENETICS SA$392.0M
- 86LXEOLexeo Therapeutics Inc.$387.1M
- 87FNCHFinch Therapeutics Group Inc.$385.5M
- 88ATHAAthira Pharma Inc.$373.5M
- 89CMPXCompass Therapeutics Inc.$363.8M
- 90ZURAZura Bio Limited$356.2M
- 91GLSGelesis Holdings Inc.$341.6M
- 92IKNAIkena Oncology Inc.$339.0M
- 93GRTSGritstone bio Inc.$336.5M
- 94FUSNFusion Pharmaceuticals Inc.$330.7M
- 95AERIAerie Pharmaceuticals Inc.$327.7M
- 96PALIPalisade Bio Inc.$324.6M
- 97OPTOpthea Limited$314.4M
- 98FENCFennec Pharmaceuticals Inc.$312.9M
- 99ORTXOrchard Therapeutics plc$308.4M
- 100SABSSAB Biotherapeutics Inc.$305.9M
- 101LCTXLineage Cell Therapeutics Inc.$301.7M
- 102PSTXPoseida Therapeutics Inc.$288.8M
- 103IVVDInvivyd Inc.$285.7M
- 104FLAGFirst Light Acquisition Group Inc.$282.6M
- 105NMRANeumora Therapeutics Inc.$279.8M
- 106SRZNSurrozen Inc.$269.9M
- 107EDITEditas Medicine Inc.$263.4M
- 108ARMPArmata Pharmaceuticals Inc.$259.9M
- 109AVXLAnavex Life Sciences Corp.$253.0M
- 110FATEFate Therapeutics Inc.$243.6M
- 111ARTVArtiva Biotherapeutics Inc.$242.7M
- 112IKTInhibikase Therapeutics Inc.$241.6M
- 113CHRSCoherus Oncology Inc.$228.3M
- 114VYGRVoyager Therapeutics Inc.$224.8M
- 115TARAProtara Therapeutics Inc.$223.7M
- 116OTLKOutlook Therapeutics Inc.$221.3M
- 117HUMAHumacyte Inc.$205.2M
- 118ALECAlector Inc.$194.3M
- 119LENZLENZ Therapeutics Inc.$192.8M
- 120CGENCompugen Ltd.$190.1M
- 121ARYDARYA Sciences Acquisition Corp IV$189.0M
- 122PLXProtalix BioTherapeutics Inc. (DE)$178.9M
- 123CRTXCortexyme Inc.$178.7M
- 124DTILPrecision BioSciences Inc.$175.7M
- 125VCKAVickers Vantage Corp. I$174.1M
- 126GMDAGamida Cell Ltd.$173.7M
- 127GNFTGENFIT S.A.$171.9M
- 128VECTVectivBio Holding AG$171.1M
- 129IPHAInnate Pharma S.A. ADS$169.8M
- 130ABOSAcumen Pharmaceuticals Inc.$163.2M
- 131CRBUCaribou Biosciences Inc.$162.7M
- 132ERYPErytech Pharma S.A.$160.1M
- 133TNYATenaya Therapeutics Inc.$158.5M
- 134MOLNMolecular Partners AG$154.2M
- 135ADVMAdverum Biotechnologies Inc.$152.1M
- 136SURFSurface Oncology Inc.$138.5M
- 137EIGREiger BioPharmaceuticals Inc.$133.5M
- 138CGTXCognition Therapeutics Inc.$129.8M
- 139AGENAgenus Inc.$124.9M
- 140MBOTMicrobot Medical Inc.$124.9M
- 141TCRRTCR2 Therapeutics Inc.$123.1M
- 142CRDLCardiol Therapeutics Inc.$122.2M
- 143ADOCEdoc Acquisition Corp.$121.0M
- 144LJPCLa Jolla Pharmaceutical Company$120.0M
- 145FRLNFreeline Therapeutics Holdings plc$116.7M
- 146ENGNenGene Therapeutics Inc.$115.2M
- 147KLRSKalaris Therapeutics Inc.$112.3M
- 148BCLIBrainstorm Cell Therapeutics Inc.$111.4M
- 149APTOAptose Biosciences Inc.$106.7M
- 150COEPCoeptis Therapeutics Holdings Inc.$102.1M
- 151PTHSPelthos Therapeutics Inc.$100.8M
- 152BDTXBlack Diamond Therapeutics Inc.$95.1M
- 153ELEVElevation Oncology Inc.$94.3M
- 154BHSEBull Horn Holdings Corp.$93.8M
- 155ATRAAtara Biotherapeutics Inc.$90.7M
- 156CSBRChampions Oncology Inc.$87.8M
- 157CRDFCardiff Oncology Inc.$82.7M
- 158AGTCApplied Genetic Technologies Corporation$81.4M
- 159GNTAGenenta Science S.p.A.$81.0M
- 160AVROAVROBIO Inc.$80.8M
- 161MIROMiromatrix Medical Inc.$80.6M
- 162LONALeonaBio Inc.$76.8M
- 163KLDOKaleido Biosciences Inc.$74.1M
- 164SGMOSangamo Therapeutics Inc.$73.6M
- 165IMAImageneBio Inc.$67.7M
- 166EXOZeXoZymes Inc.$66.7M
- 167SCLXScilex Holding Company$63.4M
- 168XTNTXtant Medical Holdings Inc.$61.8M
- 169INKTMiNK Therapeutics Inc.$60.5M
- 170TCRXTScan Therapeutics Inc.$60.1M
- 171ENTXEntera Bio Ltd.$59.6M
- 172UPTDTradeUP Acquisition Corp.$58.0M
- 173AXLAAxcella Health Inc.$57.6M
- 174CDTXCidara Therapeutics Inc.$57.4M
- 175OKYOOKYO Pharma Limited$53.8M
- 176PSTIPluristem Therapeutics Inc.$52.3M
- 177TILInstil Bio Inc.$50.9M
- 178ELUTElutia Inc.$46.9M
- 179MGXMetagenomi Therapeutics Inc.$45.2M
- 180TCONTRACON Pharmaceuticals Inc.$45.1M
- 181ATYRaTyr Pharma Inc.$44.2M
- 182ODTOdonate Therapeutics Inc.$43.1M
- 183ESLAEstrella Immunopharma Inc.$40.9M
- 184TVGNTevogen Bio Holdings Inc.$39.9M
- 185ELOXEloxx Pharmaceuticals Inc.$39.7M
- 186PTEPolarityTE Inc.$38.9M
- 187INMBINmune Bio Inc.$38.5M
- 188IMRAIMARA Inc.$36.3M
- 189ALGSAligos Therapeutics Inc.$32.7M
- 190IDRAIdera Pharmaceuticals Inc.$31.1M
- 191BVXVBiondVax Pharmaceuticals Ltd.$30.8M
- 192CYTHCyclo Therapeutics Inc.$30.5M
- 193WINTWindtree Therapeutics Inc.$30.0M
- 194SNTISenti Biosciences Inc.$29.0M
- 195DYAIDyadic International Inc.$28.5M
- 196GENEGenetic Technologies Ltd$27.0M
- 197EVAXEvaxion A/S$25.4M
- 198ONVOOrganovo Holdings Inc.$25.4M
- 199BBIBrickell Biotech Inc.$23.8M
- 200PLURPluri Inc.$21.8M